Amsino Healthcare (USA) Inc.

Form 483 issued December 19, 2022 · Vernon Hills, Illinois

Inspection
Dec 5 – Dec 19, 2022
Observations
16
Pages
21
FEI number
1417519

In short: On December 19, 2022, FDA issued a Form 483 with 16 observations to Amsino Healthcare (USA) Inc. in Vernon Hills, Illinois (FEI 1417519) after an inspection that ran Dec 5 – Dec 19, 2022. The investigators were Joseph A. Piechocki, Shafig Ahadi, Shafiq S. Ahadi and Simone E. Pitts. Most observations concern design controls and cAPA; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

Observations span 4 systems, led by design controls.

Design controls4
CAPA3
Quality system2
Production2
Other5

What FDA observed

Preview: the opening words of each observation
  1. 01

    A device master record…

  2. 02

    Written MDR procedures have…

  3. 03

    Procedures for design change…

  4. 04

    The design history file…

12 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Amsino Healthcare (USA) Inc.?

FDA listed 16 observations on this Form 483, mostly about design controls, cAPA and quality system. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Amsino Healthcare (USA) Inc.?

Joseph A. Piechocki, Shafig Ahadi, Shafiq S. Ahadi and Simone E. Pitts are named on this Form 483, for the inspection of Dec 5 – Dec 19, 2022. Each investigator has a profile showing what they cite most.

When was Amsino Healthcare (USA) Inc. inspected by FDA?

The inspection ran Dec 5 – Dec 19, 2022, and the Form 483 is dated December 19, 2022.

How do I get the full Form 483 for Amsino Healthcare (USA) Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free